Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525224 · ClinicalTrials.gov registry record · NA
Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults
A NA study, sponsored by Pharmanex.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02525224: Completed NA study, sponsored by Pharmanex.
NCT02525224 is a NA study that has completed, run by Pharmanex. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02525224, a NA study, has completed, sponsored by Pharmanex.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Healthy skin has been equated with a healthy diet leading to the "inside out" approach to skin health. Since the skin is the barrier to the external world, healthy skin should lead to overall better health. Conversely, the skin derives its nutrition from the internal body requiring the consumption of nutritional supplements for optimal health. This research attempts to examine skin attributes and improved appearance achieved after consumption of a state-of-the-art dietary supplement.
Primary Outcome
The primary efficacy endpoint is to determine the effects of a nutritional supplement on cellular protection of the skin induced by UV radiation in generally healthy adults as determined by a reduction in sunburn cell count following supplement ingestion for 8 weeks.
Interventions
- DIETARY_SUPPLEMENT Nutritional Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-07 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT02525224 record still lists
NCT02525224 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Nutritional Supplement is the first listed.
NCT02525224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02525224 about?
NCT02525224 is a clinical study titled "Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults". Healthy skin has been equated with a healthy diet leading to the "inside out" approach to skin health. Since the skin is the barrier to the external world, healthy skin should lead to overall better health. Conversely, the skin derives its nutrition from the internal body requiring the consumption o...
What is the current status of trial NCT02525224?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02525224?
The interventions under investigation include: Nutritional Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02525224?
This trial is sponsored by Pharmanex, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02525224's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia